Copyright © 2011 Jean-François Cloix and Tobias Hévor. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. L. Netchiporouk, N. Shram, D. Salvert, and R. Cespuglio, “Brain extracellular glucose assessed by voltammetry throughout the rat sleep-wake cycle,” European Journal of Neuroscience, vol. 13, no. 7, pp. 1429–1434, 2001. View at Publisher · View at Google Scholar · View at Scopus
2. M. Fillenz and J. P. Lowry, “The relation between local cerebral blood flow and extracellular glucose concentration in rat striatum,” Experimental Physiology, vol. 83, no. 2, pp. 233–238, 1998. View at Scopus
3. J. P. Lowry, M. Demestre, and M. Fillenz, “Relation between cerebral blood flow and extracellular glucose in rat striatum during mild hypoxia and hyperoxia,” Developmental Neuroscience, vol. 20, no. 1, pp. 52–58, 1998. View at Publisher · View at Google Scholar · View at Scopus
4. M. Fillenz and J. P. Lowry, “Studies of the source of glucose in the extracellular compartment of the rat brain,” Developmental Neuroscience, vol. 20, no. 4-5, pp. 365–368, 1998. View at Publisher · View at Google Scholar · View at Scopus
5. J. P. Lowry, M. Miele, R. D. O'Neill, M. G. Boutelle, and M. Fillenz, “An amperometric glucose-oxidase/poly(o-phenylenediamine) biosensor for monitoring brain extracellular glucose: in vivo characterisation in the striatum of freely-moving rats,” Journal of Neuroscience Methods, vol. 79, no. 1, pp. 65–74, 1998. View at Publisher · View at Google Scholar · View at Scopus
6. J. P. Lowry, R. D. O'Neill, M. G. Boutelle, and M. Fillenz, “Continuous monitoring of extracellular glucose concentrations in the striatum of freely moving rats with an implanted glucose biosensor,” Journal of Neurochemistry, vol. 70, no. 1, pp. 391–396, 1998. View at Scopus
7. M. J. Birnbaum, H. C. Haspel, and O. M. Rosen, “Cloning and characterization of a cDNA encoding the rat brain glucose-transporter protein,” Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 16, pp. 5784–5788, 1986. View at Scopus
8. W. Sivitz, S. DeSautel, P. S. Walker, and J. E. Pessin, “Regulation of the glucose transporter in developing rat brain,” Endocrinology, vol. 124, no. 4, pp. 1875–1880, 1989. View at Scopus
9. F. Maher, S. Vannucci, J. Takeda, and I. A. Simpson, “Expression of mouse-GLUT3 and human-GLUT3 glucose transporter proteins in brain,” Biochemical and Biophysical Research Communications, vol. 182, no. 2, pp. 703–711, 1992. View at Scopus
10. S. I. Harik, R. N. Kalaria, L. Andersson, P. Lundahl, and G. Perry, “Immunocytochemical localization of the erythroid glucose transporter: abundance in tissues with barrier functions,” Journal of Neuroscience, vol. 10, no. 12, pp. 3862–3872, 1990. View at Scopus
11. C. L. Farrell and W. M. Pardridge, “Blood-brain barrier glucose transporter is asymmetrically distributed on brain capillary endothelial lumenal and ablumenal membranes: an electron microscopic immunogold study,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 13, pp. 5779–5783, 1991. View at Publisher · View at Google Scholar · View at Scopus
12. F. Maher, S. J. Vannucci, and I. A. Simpson, “Glucose transporter proteins in brain,” FASEB Journal, vol. 8, no. 13, pp. 1003–1011, 1994. View at Scopus
13. F. Maher and I. A. Simpson, “The GLUT3 glucose transporter is the predominant isoform in primary cultured neurons: assessment by biosynthetic and photoaffinity labelling,” Biochemical Journal, vol. 301, no. 2, pp. 379–384, 1994. View at Scopus
14. T. J. Wheeler, I. A. Simpson, and D. C. Sogin, “Detection of the rat adipose cell glucose transporter with antibody against the human red cell glucose transporter,” Biochemical and Biophysical Research Communications, vol. 105, no. 1, pp. 89–116, 1982.
15. F. Maher and I. A. Simpson, “Modulation of expression of glucose transporters GLUT3 and GLUT1 by potassium and N-methyl-D-aspartate in cultured cerebellar granule neurons,” Molecular and Cellular Neurosciences, vol. 5, no. 4, pp. 369–375, 1994. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
16. W. H. Lee and C. A. Bondy, “Ischemic injury induces brain glucose transporter gene expression,” Endocrinology, vol. 133, no. 6, pp. 2540–2544, 1993. View at Publisher · View at Google Scholar · View at Scopus
17. D. Z. Gerhart, R. L. Leino, W. E. Taylor, N. D. Borson, and L. R. Drewes, “GLUT1 and GLUT3 gene expression in gerbil brain following brief ischemia: an in situ hybridization study,” Molecular Brain Research, vol. 25, no. 3-4, pp. 313–322, 1994. View at Publisher · View at Google Scholar · View at Scopus
18. S. Nagamatsu, H. Sawa, K. Kamada, Y. Nakamichi, K. Yoshimoto, and T. Hoshino, “Neuron-specific glucose transporter (NSGT): CNS distribution of GLUT3 rat glucose transporter (RGT3) in rat central neurons,” FEBS Letters, vol. 334, no. 3, pp. 289–295, 1993. View at Publisher · View at Google Scholar · View at Scopus
19. A. L. McCall, A. M. Van Bueren, M. Moholt-Siebert, N. J. Cherry, and W. R. Woodward, “Immunohistochemical localization of the neuron-specific glucose transporter (GLUT3) to neuropil in adult rat brain,” Brain Research, vol. 659, no. 1-2, pp. 292–297, 1994. View at Scopus
20. D. Z. Gerhart, M. A. Broderius, N. D. Borson, and L. R. Drewes, “Neurons and microvessels express the brain glucose transporter protein GLUT3,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 2, pp. 733–737, 1992. View at Scopus
21. D. Janigro, “Blood-brain barrier, ion homeostasis and epilepsy: possible implications towards the understanding of ketogenic diet mechanisms,” Epilepsy Research, vol. 37, no. 3, pp. 223–232, 1999. View at Publisher · View at Google Scholar · View at Scopus
22. I. A. Simpson, A. Carruthers, and S. J. Vannucci, “Supply and demand in cerebral energy metabolism: the role of nutrient transporters,” Journal of Cerebral Blood Flow and Metabolism, vol. 27, no. 11, pp. 1766–1791, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
23. E. Oby and D. Janigro, “The blood-brain barrier and epilepsy,” Epilepsia, vol. 47, no. 11, pp. 1761–1774, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
24. J. Rao, G. Oz, and E. R. Seaquist, “Regulation of cerebral glucose metabolism,” Minerva Endocrinologica, vol. 31, no. 2, pp. 149–158, 2006. View at Scopus
25. A. M. Brown and B. R. Ransom, “Astrocyte glycogen and brain energy metabolism,” Glia, vol. 55, no. 12, pp. 1263–1271, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
26. L. Hertz, “The astrocyte-neuron lactate shuttle: a challenge of a challenge,” Journal of Cerebral Blood Flow and Metabolism, vol. 24, no. 11, pp. 1241–1248, 2004. View at Scopus
27. L. Pellerin, G. Bonvento, J.-Y. Chatton, K. Pierre, and P. J. Magistretti, “Role of neuron-glia interaction in the regulation of brain glucose utilization,” Diabetes, Nutrition and Metabolism, vol. 15, no. 5, pp. 268–273, 2002.
28. L. Pellerin, A. K. Bouzier-Sore, A. Aubert et al., “Activity-dependent regulation of energy metabolism by astrocytes: an update,” Glia, vol. 55, no. 12, pp. 1251–1262, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
29. P. J. Magistretti and L. Pellerin, “The contribution of astrocytes to the 18F-2-deoxyglucose signal in PET activation studies,” Molecular Psychiatry, vol. 1, no. 6, pp. 445–452, 1996. View at Scopus
30. I. Y. Choi, E. R. Seaquist, and R. Gruetter, “Effect of hypoglycemia on brain glycogen metabolism in vivo,” Journal of Neuroscience Research, vol. 72, no. 1, pp. 25–32, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
31. P. J. Roach, A. V. Skurat, and R. A. Harris, “Regulation of glycogen metabolism,” in Handbook of Physiology, L. S. Jefferson and A. D. Cherrington, Eds., pp. 609–647, Oxford University Press, New York, NY, USA, 2001.
32. P. J. Roach, “Glycogen and its metabolism,” Current Molecular Medicine, vol. 2, no. 2, pp. 101–120, 2002. View at Scopus
33. J. Lomako, W. M. Lomako, and W. J. Whelan, “A self-glycosylating protein is the primer for rabbit muscle glycogen biosynthesis,” FASEB Journal, vol. 2, no. 15, pp. 3097–3103, 1988. View at Scopus
34. J. Pitcher, C. Smythe, and P. Cohen, “Glycogenin is the priming glucosyltransferase required for the initiation of glycogen biogenesis in rabbit skeletal muscle,” European Journal of Biochemistry, vol. 176, no. 2, pp. 391–395, 1988. View at Scopus
35. C. Smythe and P. Cohen, “The discovery of glycogenin and the priming mechanism for glycogen biogenesis,” European Journal of Biochemistry, vol. 200, no. 3, pp. 625–631, 1991. View at Scopus
36. M. D. Alonso, J. Lomako, W. M. Lomako, and W. J. Whelan, “A new look at the biogenesis of glycogen,” FASEB Journal, vol. 9, no. 12, pp. 1126–1137, 1995. View at Scopus
37. L. F. Leloir, J. M. Olavarría, S. H. Goldemberg, and H. Carminatti, “Biosynthesis of glycogen from uridine diphosphate glucose,” Archives of Biochemistry and Biophysics, vol. 81, no. 2, pp. 508–520, 1959.
38. S. M. Crosson, A. Khan, J. Printen, J. E. Pessin, and A. R. Saltiel, “PTG gene deletion causes impaired glycogen synthesis and developmental insulin resistance,” Journal of Clinical Investigation, vol. 111, no. 9, pp. 1423–1432, 2003. View at Publisher · View at Google Scholar · View at Scopus
39. C. Lerín, E. Montell, H. K. Berman, C. B. Newgard, and A. M. Gómez-Foix, “Overexpression of protein targeting to glycogen in cultured human muscle cells stimulates glycogen synthesis independent of glycogen and glucose 6-phosphate levels,” Journal of Biological Chemistry, vol. 275, no. 51, pp. 39991–39995, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
40. J. A. Printen, M. J. Brady, and A. R. Saltiel, “PTG, a protein phosphate 1-binding protein with a role in glycogen metabolism,” Science, vol. 275, no. 5305, pp. 1475–1478, 1997. View at Publisher · View at Google Scholar · View at Scopus
41. J. F. Cloix, M. Y. Ardourel, and T. Hévor, “Glycogen metabolism and brain pathologies,” Central Nervous System Agents in Medicinal Chemistry, vol. 8, no. 3, pp. 187–197, 2008. View at Publisher · View at Google Scholar
42. A. M. Brown, R. Wender, and B. R. Ransom, “Metabolic substrates other than glucose support axon function in central white matter,” Journal of Neuroscience Research, vol. 66, no. 5, pp. 839–843, 2001. View at Publisher · View at Google Scholar · View at PubMed
43. J. M. Medina and A. Tabernero, “Lactate utilization by brain cells and its role in CNS development,” Journal of Neuroscience Research, vol. 79, no. 1-2, pp. 2–10, 2005. View at Publisher · View at Google Scholar · View at PubMed
44. L. Pellerin, G. Pellegri, J. L. Martin, and P. J. Magistretti, “Expression of monocarboxylate transporter mRNAs in mouse brain: support for a distinct role of lactate as an energy substrate for the neonatal vs. adult brain,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 7, pp. 3990–3995, 1998. View at Publisher · View at Google Scholar
45. H. Wiesinger, B. Hamprecht, and R. Dringen, “Metabolic pathways for glucose in astrocytes,” Glia, vol. 21, no. 1, pp. 22–34, 1997. View at Publisher · View at Google Scholar
46. P. J. Magistretti, “Neuron-glia metabolic coupling and plasticity,” Journal of Experimental Biology, vol. 209, no. 12, pp. 2304–2311, 2006. View at Publisher · View at Google Scholar · View at PubMed
47. P. J. Magistretti, L. Pellerin, D. L. Rothman, and R. G. Shulman, “Energy on demand,” Science, vol. 283, no. 5401, pp. 496–497, 1999. View at Publisher · View at Google Scholar
48. D. L. Rothman, N. R. Sibson, F. Hyder, J. Shen, K. L. Behar, and R. G. Shulman, “In vivo nuclear magnetic resonance spectroscopy studies of the relationship between the glutamate-glutamine neurotransmitter cycle and functional neuroenergetics,” Philosophical Transactions of the Royal Society B, vol. 354, no. 1387, pp. 1165–1177, 1999.
49. N. R. Sibson, A. Dhankhar, G. F. Mason, D. L. Rothman, K. L. Behar, and R. G. Shulman, “Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 1, pp. 316–321, 1998. View at Publisher · View at Google Scholar
50. A. M. Brown, “Brain glycogen re-awakened,” Journal of Neurochemistry, vol. 89, no. 3, pp. 537–552, 2004.
51. A. M. Brown, S. B. Tekkök, and B. R. Ransom, “Energy transfer from astrocytes to axons: the role of CNS glycogen,” Neurochemistry International, vol. 45, no. 4, pp. 529–536, 2004. View at Publisher · View at Google Scholar · View at PubMed
52. A. M. Brown, H. M. Sickmann, K. Fosgerau et al., “Astrocyte glycogen metabolism is required for neural activity during aglycemia or intense stimulation in mouse white matter,” Journal of Neuroscience Research, vol. 79, no. 1-2, pp. 74–80, 2005. View at Publisher · View at Google Scholar · View at PubMed
53. K. Pierre and L. Pellerin, “Monocarboxylate transporters in the central nervous system: distribution, regulation and function,” Journal of Neurochemistry, vol. 94, no. 1, pp. 1–14, 2005. View at Publisher · View at Google Scholar · View at PubMed
54. D. Govender, P. K. Ramdial, B. Clarke, and R. Chetty, “Clear cell (glycogen-rich) gastric adenocarcinoma,” Annals of Diagnostic Pathology, vol. 8, no. 2, pp. 69–73, 2004. View at Publisher · View at Google Scholar
55. J. Albores-Saavedra, X. Gu, and M. A. Luna, “Clear cells and thyroid transcription factor I reactivity in sclerosing mucoepidermoid carcinoma of the thyroid gland,” Annals of Diagnostic Pathology, vol. 7, no. 6, pp. 348–353, 2003. View at Publisher · View at Google Scholar
56. F. Gorin, W. Harley, J. Schnier, B. Lyeth, and T. Jue, “Perinecrotic glioma proliferation and metabolic profile within an intracerebral tumor xenograft,” Acta Neuropathologica, vol. 107, no. 3, pp. 235–244, 2004. View at Publisher · View at Google Scholar · View at PubMed
57. O. H. Lowry, S. J. Berger, and J. G. Carter, “Diversity of metabolic patterns in human brain tumors: enzymes of energy metabolism and related metabolites and cofactors,” Journal of Neurochemistry, vol. 41, no. 4, pp. 994–1010, 1983.
58. M. Rousset, A. Zweibaum, and J. Fogh, “Presence of glycogen and growth-related variations in 58 cultured human tumor cell lines of various tissue origins,” Cancer Research, vol. 41, no. 3, pp. 1165–1170, 1981.
59. T. Sato, A. Nakamura, H. Shibuya, W. Shirai, and H. Koie, “Cerebral high-grade astrocytoma (glioblastoma) in a cat,” Journal of Veterinary Medicine Series A, vol. 50, no. 5, pp. 269–271, 2003. View at Publisher · View at Google Scholar
60. M. Wrensch, T. Rice, R. Miike et al., “Diagnostic, treatment, and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area,” Neuro-Oncology, vol. 8, no. 1, pp. 12–26, 2006. View at Publisher · View at Google Scholar · View at PubMed
61. M. E. Beckner, G. T. Gobbel, R. Abounader et al., “Glycolytic glioma cells with active glycogen synthase are sensitive to PTEN and inhibitors of PI3K and gluconeogenesis,” Laboratory Investigation, vol. 85, no. 12, pp. 1457–1470, 2005. View at Publisher · View at Google Scholar · View at PubMed
62. O. Mbarek, V. Vergé, and T. Hevor, “Direct cloning of astrocytes from primary culture without previous immortalization,” In Vitro Cellular and Developmental Biology—Animal, vol. 34, no. 5, pp. 401–411, 1998.
63. R. A. Gatenby and R. J. Gillies, “Why do cancers have high aerobic glycolysis?” Nature Reviews Cancer, vol. 4, no. 11, pp. 891–899, 2004. View at Publisher · View at Google Scholar · View at PubMed
64. R. J. Shaw, “Glucose metabolism and cancer,” Current Opinion in Cell Biology, vol. 18, no. 6, pp. 598–608, 2006. View at Publisher · View at Google Scholar · View at PubMed
65. E. D. Michelakis, G. Sutendra, P. Dromparis et al., “Metabolic modulation of glioblastoma with dichloroacetate,” Science Translational Medicine, vol. 2, no. 31, p. 31ra34, 2010. View at Publisher · View at Google Scholar · View at PubMed
66. F. E. Dreifuss, M. Martinez-Lage, and J. Roger, “Proposal for classification of epilepsies and epileptic syndromes,” Epilepsia, vol. 26, no. 3, pp. 268–278, 1985.
67. F. E. Dreifuss, “Classification of the epilepsies: influence on management,” Revue Neurologique, vol. 143, no. 5, pp. 375–380, 1987.
68. H. G. Wieser, W. T. Blume, D. Fish et al., “Proposal for a new classification of outcome with respect to epileptic seizures following epilepsy surgery,” Epilepsia, vol. 42, no. 2, pp. 282–286, 2001. View at Publisher · View at Google Scholar
69. J. Roger, F. E. Dreifuss, M. Martinez-Lage et al., “Proposal for revised classification of epilepsies and epileptic syndromes,” Epilepsia, vol. 30, no. 4, pp. 389–399, 1989.
70. F. E. Dreifuss, J. Bancaud, and O. Henriksen, “Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy,” Epilepsia, vol. 22, no. 4, pp. 489–501, 1981.
71. A. D. Everitt and J. W.A.S. Sande, “Classification of the epilepsies: time for a change?” European Neurology, vol. 42, no. 1, pp. 1–10, 1999. View at Publisher · View at Google Scholar
72. S. Rampp and H. Stefan, “Fast activity as a surrogate marker of epileptic network function?” Clinical Neurophysiology, vol. 117, no. 10, pp. 2111–2117, 2006. View at Publisher · View at Google Scholar · View at PubMed
73. M. V. Johnston, “Developmental aspects of epileptogenesis,” Epilepsia, vol. 37, no. 1, pp. S2–S9, 1996.
74. F. E. Dudek, P. R. Patrylo, and J. P. Wuarin, “Mechanisms of neuronal synchronization during epileptiform activity,” Advances in Neurology, vol. 79, pp. 699–708, 1999.
75. D. A. McCormick and D. Contreras, “On the cellular and network bases of epileptic seizures,” Annual Review of Physiology, vol. 63, pp. 815–846, 2001. View at Publisher · View at Google Scholar · View at PubMed
76. P. J. Uhlhaas and W. Singer, “Neural synchrony in brain disorders: relevance for cognitive dysfunctions and pathophysiology,” Neuron, vol. 52, no. 1, pp. 155–168, 2006. View at Publisher · View at Google Scholar · View at PubMed
77. H. E. Scharfman, “The neurobiology of epilepsy,” Current Neurology and Neuroscience Reports, vol. 7, no. 4, pp. 348–354, 2007. View at Publisher · View at Google Scholar
78. J. Engel Jr., W. J. Brown, and D. E. Kuhl, “Pathological findings underlying focal temporal lobe hypometabolism in partial epilepsy,” Annals of Neurology, vol. 12, no. 6, pp. 518–528, 1982.
79. J. Engel Jr., D. E. Kuhl, and M. E. Phelps, “Local cerebral metabolism during partial seizures,” Neurology, vol. 33, no. 4, pp. 400–413, 1983.
80. Y. Y. Sitoh and R. D. Tien, “Neuroimaging in epilepsy,” Journal of Magnetic Resonance Imaging, vol. 8, no. 2, pp. 277–288, 1998. View at Publisher · View at Google Scholar
81. M. K. Dalsgaard, F. F. Madsen, N. H. Secher, H. Laursen, and B. Quistorff, “High glycogen levels in the hippocampus of patients with epilepsy,” Journal of Cerebral Blood Flow and Metabolism, vol. 27, no. 6, pp. 1137–1141, 2007. View at Publisher · View at Google Scholar · View at PubMed
82. K. Bernard-Hélary, M. Y. Ardourel, T. Hévor, and J. F. Cloix, “In vivo and in vitro glycogenic effects of methionine sulfoximine are different in two inbred strains of mice,” Brain Research, vol. 929, no. 2, pp. 147–155, 2002. View at Publisher · View at Google Scholar
83. P. Delorme and T. K. Hevor, “Glycogen particles in méthionine sulfoximine epileptogenic rodent brain and liver after the administration of methionine and actinomycin D,” Neuropathology and Applied Neurobiology, vol. 11, no. 2, pp. 117–128, 1985.
84. T. K. Hevor, “Some aspects of carbohydrate metabolism in the brain,” Biochimie, vol. 76, no. 2, pp. 111–120, 1994. View at Publisher · View at Google Scholar
85. T. K. Hevor and P. Delorme, “Biochemical and ultrastructural study of glycogen in cultured astrocytes submitted to the convulsant methionine sulfoximine,” Glia, vol. 4, no. 1, pp. 64–69, 1991.
86. T. K. Hevor, P. Delorme, and J. C. Beauvillain, “Glycogen synthesis and immunocytochemical study of fructose-1,6-biphosphatase in methionine sulfoximine epileptogenic rodent brain,” Journal of Cerebral Blood Flow and Metabolism, vol. 6, no. 3, pp. 292–297, 1986.
87. C. H. Phelps, “An ultrastructural study of methionine sulphoximine induced glycogen accumulation in astrocytes of the mouse cerebral cortex,” Journal of Neurocytology, vol. 4, no. 4, pp. 479–490, 1975.
88. J. Folbergrová, “Glycogen and glycogen phosphorylase in the cerebral cortex of mice under the influence of methionine sulphoximine,” Journal of Neurochemistry, vol. 20, no. 2, pp. 547–557, 1973.
89. J. Folbergrová, J. V. Passonneau, O. H. Lowry, and D. W. Schulz, “Glycogen, ammonia and related metabolities in the brain during seizures evoked by methionine sulphoximine,” Journal of Neurochemistry, vol. 16, no. 2, pp. 191–203, 1969.
90. K. Bernard-Helary, E. Lapouble, M. Ardourel, T. Hévor, and J. F. Cloix, “Correlation between brain glycogen and convulsive state in mice submitted to methionine sulfoximine,” Life Sciences, vol. 67, no. 14, pp. 1773–1781, 2000. View at Publisher · View at Google Scholar
91. T. K. Hevor, P. Delorme, and J. Gayet, “Glycogen content and fructose-1, 6-biphosphatase activity in methionine sulfoximine epileptogenic mouse brain and liver after protein synthesis inhibition,” Neuropathology and Applied Neurobiology, vol. 11, no. 2, pp. 129–139, 1985.
92. J. Folbergrová, R. Druga, R. Haugvicová, P. Mareš, and J. Otáhal, “Anticonvulsant and neuroprotective effect of (S)-3,4-dicarboxyphenylglycine against seizures induced in immature rats by homocysteic acid,” Neuropharmacology, vol. 54, no. 4, pp. 665–675, 2008. View at Publisher · View at Google Scholar · View at PubMed
93. W. Wang, H. Lohi, A. V. Skurat, A. A. DePaoli-Roach, B. A. Minassian, and P. J. Roach, “Glycogen metabolism in tissues from a mouse model of Lafora disease,” Archives of Biochemistry and Biophysics, vol. 457, no. 2, pp. 264–269, 2007. View at Publisher · View at Google Scholar · View at PubMed
94. D. Vilchez, S. Ros, D. Cifuentes et al., “Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy,” Nature Neuroscience, vol. 10, no. 11, pp. 1407–1413, 2007. View at Publisher · View at Google Scholar · View at PubMed
95. E. L. Peters and D. B. Tower, “Glutamic acid and glutamine metabolism in cerebral cortex after seizures induced by methionine sulphoximine,” Journal of Neurochemistry, vol. 5, pp. 80–90, 1959.
96. A. Meister, “Inhibition of glutamine synthase and gamma glutamylcysteine synthetase by methionine sulfoximine and related compounds,” in Enzyme Activated Irreversible Inhibitiors, N. Seiler, M. J. Jung, and J. Koch-Weser, Eds., pp. 187–210, Elsevier, Amsterdam, The Netherlands, 1978.
97. D. L. Somers and R. M. Beckstead, “Chronic methionine sulfoximine administration reduces synaptosomal aspartate and glutamate in rat striatum,” Neuroscience Letters, vol. 115, no. 2-3, pp. 335–340, 1990. View at Publisher · View at Google Scholar
98. F. Fonnum and R. E. Paulsen, “Comparison of transmitter amino acid levels in rat globus pallidus and neostriatum during hypoglycemia or after treatment with methionine sulfoximine or γ-vinyl γ-aminobutyric acid,” Journal of Neurochemistry, vol. 54, no. 4, pp. 1253–1257, 1990.
99. B. Engelsen and F. Fonnum, “The effect of methioninesulfoximine, an inhibitor of glutamine synthetase, on the levels of amino acids in the intact and decorticated rat neostriatum,” Brain Research, vol. 338, no. 1, pp. 165–168, 1985. View at Publisher · View at Google Scholar
100. M. Blin, W. E. Crusio, T. Hévor, and J. F. Cloix, “Chronic inhibition of glutamine synthetase is not associated with impairment of learning and memory in mice,” Brain Research Bulletin, vol. 57, no. 1, pp. 11–15, 2002. View at Publisher · View at Google Scholar
101. J. F. Cloix, E. Beaulieu, and T. Hevor, “Various fructose-1,6-bisphosphatase mRNAs in mouse brain, liver, kidney and heart,” NeuroReport, vol. 8, no. 3, pp. 617–622, 1997.
102. K. Bernard-Hélary, M. Ardourel, P. Magistretti, T. Hévor, and J. F. Cloix, “Stable transfection of cDNAs targeting specific steps of glycogen metabolism supports the existence of active gluconeogenesis in mouse cultured astrocytes,” Glia, vol. 37, no. 4, pp. 379–382, 2002. View at Publisher · View at Google Scholar · View at PubMed
103. G. Pellegri, C. Rossier, P. J. Magistretti, and J. L. Martin, “Cloning, localization and induction of mouse brain glycogen synthase,” Molecular Brain Research, vol. 38, no. 2, pp. 191–199, 1996. View at Publisher · View at Google Scholar
104. M. Ardourel, M. Blin, J. L. Moret et al., “A new putative target for antisense gene therapy of glioma: glycogen synthase,” Cancer Biology and Therapy, vol. 6, no. 5, pp. 719–723, 2007.
105. V. Vergé, A. Legrand, and T. Hévor, “Isolation of carbohydrate metabolic clones from cultured astrocytes,” Glia, vol. 18, no. 3, pp. 244–254, 1996. View at Publisher · View at Google Scholar
106. P. Benda, J. Lightbody, G. Sato, L. Levine, and W. Sweet, “Differentiated rat glial cell strain in tissue culture,” Science, vol. 161, no. 3839, pp. 370–371, 1968.
107. R. Gruetter, “In vivo 13C NMR studies of compartmentalized cerebral carbohydrate metabolism,” Neurochemistry International, vol. 41, no. 2-3, pp. 143–154, 2002. View at Publisher · View at Google Scholar
108. R. Gruetter, G. Adriany, I. Y. Choi, P. G. Henry, H. Lei, and G. Öz, “Localized in vivo 13C NMR spectroscopy of the brain,” NMR in Biomedicine, vol. 16, no. 6-7, pp. 313–338, 2003.
109. G. Öz, P. G. Henry, E. R. Seaquist, and R. Gruetter, “Direct, noninvasive measurement of brain glycogen metabolism in humans,” Neurochemistry International, vol. 43, no. 4-5, pp. 323–329, 2003. View at Publisher · View at Google Scholar
110. G. Öz, E. R. Seaquist, A. Kumar et al., “Human brain glycogen content and metabolism: implications on its role in brain energy metabolism,” American Journal of Physiology, vol. 292, no. 3, pp. E946–E951, 2007. View at Publisher · View at Google Scholar · View at PubMed
111. V. Verge and T. K. Hevor, “Regulation of fructose-1,6-bisphosphatase activity in primary cultured astrocytes,” Neurochemical Research, vol. 20, no. 9, pp. 1049–1056, 1995. View at Publisher · View at Google Scholar
112. J. F. Cloix, Z. Tahi, B. Martin, and T. Hévor, “Selection of two lines of mice based on latency to onset of methionine sulfoximine seizures,” Epilepsia, vol. 51, no. 1, pp. 118–126, 2010. View at Publisher · View at Google Scholar · View at PubMed
113. J.-F. Cloix, Z. Tahi, A. Boissonnet, and T. Hévor, “Brain glycogen and neurotransmitter levels in fast and slow methionine sulfoximine-selected mice,” Experimental Neurology, vol. 225, no. 2, pp. 274–283, 2010. View at Publisher · View at Google Scholar · View at PubMed
114. A. Boissonnet, Biological and biochemical analyses of mice selected based upon their seizures latency toward methionine sulfoximine, Thesis defence, Université of Orléans, 2011.
115. D. A. Blizard and V. Balkoski, “Tryptophan availability, central serotonergic function and methionine sulphoximine-induced convulsions,” Neuropharmacology, vol. 21, no. 1, pp. 27–30, 1982. View at Publisher · View at Google Scholar
116. T. K. Hevor and P. Delorme, “Possible involvement of indolamines in the glycogenic effect of the convulsant methionine sulfoximine in rat brain,” Experientia, vol. 46, no. 7, pp. 710–713, 1990. View at Publisher · View at Google Scholar
117. A. J. Pennington and V. W. Pentreath, “Transmitter-induced glycogenolysis and gluconeogenesis in leech segmental ganglia,” Journal de Physiologie, vol. 82, no. 4, pp. 218–228, 1987.
118. S. Verleysdonk, S. Kistner, B. Pfeiffer-Guglielmi et al., “Glycogen metabolism in rat ependymal primary cultures: regulation by serotonin,” Brain Research, vol. 1060, no. 1-2, pp. 89–99, 2005. View at Publisher · View at Google Scholar · View at PubMed
119. I. Allaman, L. Pellerin, and P. J. Magistretti, “Glucocorticoids modulate neurotransmitter-induced glycogen metabolism in cultured cortical astrocytes,” Journal of Neurochemistry, vol. 88, no. 4, pp. 900–908, 2004.
120. P. J. Magistretti, O. Sorg, N. Yu, J. L. Martin, and L. Pellerin, “Neurotransmitters regulate energy metabolism in astrocytes: implications for the metabolic trafficking between neural cells,” Developmental Neuroscience, vol. 15, no. 3-5, pp. 306–312, 1993.
121. L. Pellerin, M. Stolz, O. Sorg, J. L. Martin, C. F. Deschepper, and P. J. Magistretti, “Regulation of energy metabolism by neurotransmitters in astrocytes in primary culture and in an immortalized cell line,” Glia, vol. 21, no. 1, pp. 74–83, 1997. View at Publisher · View at Google Scholar
122. T. Otori, J. C. Friedland, G. Sinson, T. K. McIntosh, R. Raghupathi, and F. A. Welsh, “Traumatic brain injury elevates glycogen and induces tolerance to ischemia in rat brain,” Journal of Neurotrauma, vol. 21, no. 6, pp. 707–718, 2004. View at Publisher · View at Google Scholar · View at PubMed
123. L. Xu and H. Sun, “Pharmacological manipulation of brain glycogenolysis as a therapeutic approach to cerebral ischemia,” Mini-Reviews in Medicinal Chemistry, vol. 10, no. 12, pp. 1188–1193, 2010.
124. W. S. Sang, J. P. Bergher, C. M. Anderson, J. L. Treadway, K. Fosgerau, and R. A. Swanson, “Astrocyte glycogen sustains neuronal activity during hypoglycemia: studies with the glycogen phosphorylase inhibitor CP-316,819 ([R-R*,S*]-5- chloro-N-[2-hydroxy-3-(methoxymethylamino)-3-oxo-1-(phenylmethyl)propyl] -1H-indole-2-carboxamide),” Journal of Pharmacology and Experimental Therapeutics, vol. 321, no. 1, pp. 45–50, 2007. View at Publisher · View at Google Scholar · View at PubMed